Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

What You Need to Know U.S. District Judge M. Casey Rodgers, who is overseeing about 2,000 Depo-Provera lawsuits, heard oral arguments on Pfizer's federal preemption motion on Sept. 29. The judge set ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain ...

"It could be big. I think it could be as big as some of the others we've gotten here," Anapol Weiss shareholder Kila Baldwin said. In March, neurosurgeons and researchers in France published a large ...

The FDA has approved a critical label change for Pfizer's widely used Depo-Provera birth control injection, adding a warning about the risk of meningioma—a typically non-cancerous but potentially ...

Depo Provera: The Food and Drug Administration approved a label change on Friday for Pfizer’s birth control injection, Depo-Provera, alerting patients to the risk of meningioma, a tumor that develops ...